Anti-GPAA1 monoclonal antibody

Pre-made anti-GPAA1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GPAA1/GPAA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0924-Ab-1/ GM-Tg-hg-IP0924-Ab-2Anti-Human GPAA1 monoclonal antibodyHuman
GM-Tg-rg-IP0924-Ab-1/ GM-Tg-rg-IP0924-Ab-2Anti-Rat GPAA1 monoclonal antibodyRat
GM-Tg-mg-IP0924-Ab-1/ GM-Tg-mg-IP0924-Ab-2Anti-Mouse GPAA1 monoclonal antibodyMouse
GM-Tg-cynog-IP0924-Ab-1/ GM-Tg-cynog-IP0924-Ab-2Anti-Cynomolgus/ Rhesus macaque GPAA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0924-Ab-1/ GM-Tg-felg-IP0924-Ab-2Anti-Feline GPAA1 monoclonal antibodyFeline
GM-Tg-cang-IP0924-Ab-1/ GM-Tg-cang-IP0924-Ab-2Anti-Canine GPAA1 monoclonal antibodyCanine
GM-Tg-bovg-IP0924-Ab-1/ GM-Tg-bovg-IP0924-Ab-2Anti-Bovine GPAA1 monoclonal antibodyBovine
GM-Tg-equg-IP0924-Ab-1/ GM-Tg-equg-IP0924-Ab-2Anti-Equine GPAA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0924-Ab-1/ GM-Tg-hg-IP0924-Ab-2; GM-Tg-rg-IP0924-Ab-1/ GM-Tg-rg-IP0924-Ab-2;
GM-Tg-mg-IP0924-Ab-1/ GM-Tg-mg-IP0924-Ab-2; GM-Tg-cynog-IP0924-Ab-1/ GM-Tg-cynog-IP0924-Ab-2;
GM-Tg-felg-IP0924-Ab-1/ GM-Tg-felg-IP0924-Ab-2; GM-Tg-cang-IP0924-Ab-1/ GM-Tg-cang-IP0924-Ab-2;
GM-Tg-bovg-IP0924-Ab-1/ GM-Tg-bovg-IP0924-Ab-2; GM-Tg-equg-IP0924-Ab-1/ GM-Tg-equg-IP0924-Ab-2
Products NameAnti-GPAA1 monoclonal antibody
Formatmab
Target NameGPAA1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GPAA1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0924-Ag-1Recombinant multi-species GPAA1/ GAA1/ GPIBD15 protein


    Target information

    Target IDGM-IP0924
    Target NameGPAA1
    Gene ID8733,14731,300046,699887,475120,101093994,513395,100063382
    Gene Symbol and SynonymsGAA1,GPAA1,GPIBD15,hGAA1,mGAA1
    Uniprot AccessionO43292
    Uniprot Entry NameGPAA1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197858
    Target ClassificationN/A

    The target: GPAA1, gene name: GPAA1, also named as GAA1, GPIBD15, hGAA1. Posttranslational glycosylphosphatidylinositol (GPI) anchor attachment serves as a general mechanism for linking proteins to the cell surface membrane. The protein encoded by this gene presumably functions in GPI anchoring at the GPI transfer step. The mRNA transcript is ubiquitously expressed in both fetal and adult tissues. The anchor attachment protein 1 contains an N-terminal signal sequence, 1 cAMP- and cGMP-dependent protein kinase phosphorylation site, 1 leucine zipper pattern, 2 potential N-glycosylation sites, and 8 putative transmembrane domains. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.